Mediastinal Diseases: Clinical Trials

3 trials for Mediastinal Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Terminated 3
Phase 31Terminated 1

Follow Mediastinal Diseases: new trials by email Literature Review of Mediastinal Diseases trials Research Report on Mediastinal Diseases

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors
Pembrolizumab - Germ Cell Neoplasms, Testicular Neoplasms
Phase 2TerminatedNasser Hanna, M.D.122016-01-012022-07-11
Efficacy, Immunogenicity, and Safety of a Single Dose of V710 in Adult Patients Scheduled for Cardiothoracic Surgery (V710-003 AM2)
V710, Placebo - Staphylococcus Aureus, Bacteremia
Phase 2 / Phase 3TerminatedMerck Sharp & Dohme LLC80312007-12-012015-10-02
Weekly Topotecan With Docetaxel in Recurrent Small Cell Lung Cancer
Intravenous Topotecan, Intravenous Docetaxel - Mediastinal Neoplasms
Phase 2TerminatedAultman Health Foundation72004-11-012018-08-20

Narrower conditions

Mediastinal Neoplasms (2)  ·  Bacteremia (1)  ·  Genital Neoplasms, Female (1)  ·  Genital Neoplasms, Male (1)  ·  Mediastinitis (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Nonseminomatous germ cell tumor (1)  ·  Ovarian Neoplasms (1)  ·  Staphylococcal Infections (1)  ·  Testicular Neoplasms (1)

Broader conditions

Respiratory Tract Diseases (3)  ·  Thoracic Diseases (3)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Thoracic Neoplasms (2)  ·  Adnexal Diseases (1)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)

Interventions

Docetaxel (1)  ·  Topotecan (1)  ·  V710 vaccine (1)  ·  pembrolizumab (1)

Sponsors

Aultman Health Foundation (1)  ·  Merck Sharp & Dohme LLC (1)  ·  Nasser Hanna, M.D. (1)

Countries

United States (2)

Top investigators

Nasser Hanna, M.D. (1)  ·  Raza Khan, MD (1)

Results publications

PMID 23549582, PMID 29045540